{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T16:23:06Z","timestamp":1770567786047,"version":"3.49.0"},"reference-count":86,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Arrhythmia and Electrophysiology"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The treatment of heart failure with reduced ejection fraction has been the subject of numerous randomized controlled trials involving medications and cardiac implantable electronic device therapies. As newer effective pharmacological therapies suggest significant reductions in all-cause mortality, the role of additional device therapy in heart failure with reduced ejection fraction deserves further scrutiny.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A systematic review and network meta-analysis on the effect of medication and device therapies in heart failure with reduced ejection fraction on all-cause mortality was performed. Randomized controlled trials published between January 1980 and July 2017 were identified using Medline, EMBASE, and Cochrane Controlled Register of Trials databases. Pcnetmeta package in R was used to calculate treatment arm\u2013based estimated rates, rate ratios, and probability ranks with 95% credible intervals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Combination therapy of ACE (angiotensin-converting enzyme) inhibitors or ARBs (angiotensin receptor blockers) with \u03b2-blockers (BBs) alone or in addition to implantable cardiac defibrillators or cardiac resynchronization therapy with defibrillators demonstrated a significant reduction of all-cause mortality when compared with placebo. By probability rank, implantable cardiac defibrillator+ACE inhibitor or ARB+BB+mineralocorticoid receptor antagonist, implantable cardiac defibrillator+ACE inhibitor or ARB+BB, and angiotensin receptor-neprilysin inhibitor+BB+mineralocorticoid receptor antagonist combination therapies have the highest probability of being ranked the best treatment. There was no significant difference in the rate of mortality when comparing angiotensin receptor-neprilysin inhibitor+BB+mineralocorticoid receptor antagonist to implantable cardiac defibrillator+optimal pharmacological combination therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>BB and renin-angiotensin system blockers alone or in combination with defibrillator device therapy have robust evidence for a reduction in mortality compared with placebo. The comparative efficacy of pharmacological therapy with angiotensin receptor-neprilysin inhibitors and device therapy deserves further investigation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/circep.118.006951","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T09:01:45Z","timestamp":1559638905000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction"],"prefix":"10.1161","volume":"12","author":[{"given":"Andrew S.","family":"Tseng","sequence":"first","affiliation":[{"name":"Department of Internal Medicine (A.S.T.), Mayo Clinic Arizona, Phoenix."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie L.","family":"Kunze","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics (K.L.K., M.R.N.), Mayo Clinic Arizona, Phoenix."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin Z.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases (J.Z.L., S.K.M.), Mayo Clinic Arizona, Phoenix."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha","family":"Amin","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Rochester, MN (M.A., A.M.K., M.M., Y.-M.C., S.J.A., P.A.F., B.J.G.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Neville","sequence":"additional","affiliation":[{"name":"Division of Biomedical Statistics and Informatics (K.L.K., M.R.N.), Mayo Clinic Arizona, Phoenix."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Almader-Douglas","sequence":"additional","affiliation":[{"name":"Mayo Clinic Library Services (D.A.-D.), Mayo Clinic Arizona, Phoenix."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammar M.","family":"Killu","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Rochester, MN (M.A., A.M.K., M.M., Y.-M.C., S.J.A., P.A.F., B.J.G.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malini","family":"Madhavan","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Rochester, MN (M.A., A.M.K., M.M., Y.-M.C., S.J.A., P.A.F., B.J.G.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Mei","family":"Cha","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Rochester, MN (M.A., A.M.K., M.M., Y.-M.C., S.J.A., P.A.F., B.J.G.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel J.","family":"Asirvatham","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Rochester, MN (M.A., A.M.K., M.M., Y.-M.C., S.J.A., P.A.F., B.J.G.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Rochester, MN (M.A., A.M.K., M.M., Y.-M.C., S.J.A., P.A.F., B.J.G.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard J.","family":"Gersh","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases, Mayo Clinic Rochester, MN (M.A., A.M.K., M.M., Y.-M.C., S.J.A., P.A.F., B.J.G.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siva K.","family":"Mulpuru","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases (J.Z.L., S.K.M.), Mayo Clinic Arizona, Phoenix."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1711901"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003529"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043399"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1608029"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/1740774513498322"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v080.i05"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfn015"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.04.004"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1995.tb04107.x"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/ebm.6.6.172"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80624-9"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050496"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2003.12.019"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00192366"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000012350.99718.ad"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)00796-7"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700003-00021"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14284-5"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.4.1765"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)74355-5"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-008-6116-9"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01965-4"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-9164(97)90013-0"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90618-9"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.11.2800"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032423"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706043162301"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.6.712"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033088"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.121807"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.121269"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306687"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009492"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2004.10.015"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2004.04044.x"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060844"},{"issue":"5","key":"e_1_3_2_39_2","first-page":"V30","article-title":"The mortality effect of metoprolol CR\/XL in patients with heart failure: results of the MERIT-HF Trial.","volume":"22","author":"Goldstein S","year":"1999","unstructured":"Goldstein, S, Hjalmarson, A. The mortality effect of metoprolol CR\/XL in patients with heart failure: results of the MERIT-HF Trial. Clin Cardiol. 1999;22(suppl 5):V30\u2013V35.","journal-title":"Clin Cardiol"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)01042-8"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.6.1499"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.001239"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90411-6"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199612263352601"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013474"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906431"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.67.4.289"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(00)00078-7"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000146336.92331.D1"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.20.2685"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2003.161"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.11.2807"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912163412503"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.113.000135"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605233342101"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000159880.12067.34"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409077"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.11.2793"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009540"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.208355"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706695"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.08.027"},{"key":"e_1_3_2_65_2","first-page":"27","article-title":"Effects of fosinopril on exercise tolerance, symptoms, and clinical outcomes in patients with decompensated heart failure.","volume":"5","author":"Shettigar U","year":"1999","unstructured":"Shettigar, U, Hare, T, Gelperin, K, Ilgenfritz, JP, Deitchman, D, Blumenthal, M. Effects of fosinopril on exercise tolerance, symptoms, and clinical outcomes in patients with decompensated heart failure. Congest Heart Fail. 1999;5:27\u201334.","journal-title":"Congest Heart Fail"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108013250501"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209033271003"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(00)90037-1"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.22.2224"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(00)00120-3"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2003.12.007"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00464-1"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31829dd6b1"},{"key":"e_1_3_2_74_2","unstructured":"U.S. Food and Drug Administration. Summary of safety and effectiveness data. RHYTHM ICD. 2005. www.accessdata.fda.gov\/cdrh_docs\/pdf3\/P030054b.pdf. Accessed February 9 2018."},{"key":"e_1_3_2_75_2","volume-title":"In:Methods in Comparative Effectiveness Research","author":"Hong H","year":"2016","unstructured":"Hong, H, Price, KL, Fu, H, Carlin, BP. Bayesian network meta-analysis for multiple endpoints. Morton, S, Gatsonis, C, eds. In:Methods in Comparative Effectiveness Research. Boca Raton, FL: CRC Press; 2016."},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.028829"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-011-6313-9"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-011-9584-y"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-154-6-201103150-00313"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016352"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12253"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.21037\/cdt.2017.06.06"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-017-0260-8"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.7326\/L17-0692"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.897249"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2016.03.026"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.87.2.177"}],"container-title":["Circulation: Arrhythmia and Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCEP.118.006951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:02:44Z","timestamp":1715558564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCEP.118.006951"}},"subtitle":["A Systematic Review and Network Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1161\/CIRCEP.118.006951"],"URL":"https:\/\/doi.org\/10.1161\/circep.118.006951","relation":{},"ISSN":["1941-3149","1941-3084"],"issn-type":[{"value":"1941-3149","type":"print"},{"value":"1941-3084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"2018-10-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e006951"}}